I-MAB (IMAB)
1.78
-0.02
(-1.11%)
USD |
NASDAQ |
Apr 30, 14:05
I-MAB Enterprise Value: -172.81M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 29, 2024 | -172.81M |
April 26, 2024 | -172.81M |
April 25, 2024 | -172.00M |
April 24, 2024 | -172.00M |
April 23, 2024 | -172.81M |
April 22, 2024 | -172.81M |
April 19, 2024 | -172.81M |
April 18, 2024 | -172.81M |
April 17, 2024 | -172.00M |
April 16, 2024 | -173.62M |
April 15, 2024 | -172.81M |
April 12, 2024 | -172.00M |
April 11, 2024 | -172.00M |
April 10, 2024 | -171.20M |
April 09, 2024 | -172.81M |
April 08, 2024 | -172.00M |
April 05, 2024 | -170.39M |
April 04, 2024 | -172.81M |
April 03, 2024 | -170.39M |
April 02, 2024 | -171.20M |
April 01, 2024 | -172.00M |
March 28, 2024 | -167.97M |
March 27, 2024 | -167.16M |
March 26, 2024 | -169.58M |
March 25, 2024 | -167.97M |
Date | Value |
---|---|
March 22, 2024 | -167.16M |
March 21, 2024 | -172.00M |
March 20, 2024 | -164.74M |
March 19, 2024 | -171.20M |
March 18, 2024 | -172.00M |
March 15, 2024 | -167.97M |
March 14, 2024 | -172.81M |
March 13, 2024 | -169.58M |
March 12, 2024 | -170.39M |
March 11, 2024 | -172.00M |
March 08, 2024 | -168.78M |
March 07, 2024 | -179.27M |
March 06, 2024 | -178.46M |
March 05, 2024 | -181.69M |
March 04, 2024 | -180.07M |
March 01, 2024 | -173.62M |
February 29, 2024 | -174.43M |
February 28, 2024 | -168.78M |
February 27, 2024 | -168.78M |
February 26, 2024 | -177.65M |
February 23, 2024 | -185.72M |
February 22, 2024 | -191.37M |
February 21, 2024 | -188.95M |
February 20, 2024 | -185.72M |
February 16, 2024 | -180.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-317.65M
Minimum
Dec 28 2022
5.761B
Maximum
Jul 01 2021
1.296B
Average
544.28M
Median
Feb 24 2020
Enterprise Value Benchmarks
Zai Lab Ltd | 792.79M |
WuXi Biologics (Cayman) Inc | 6.593B |
Wuxi AppTec Co Ltd | 11.82B |
Gracell Biotechnologies Inc (DELISTED) | -- |
Sinovac Biotech Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -131.0% |
Normalized Earnings Yield | -131.03 |